- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07807631
Effects of Park Golf on Working Memory and Prefrontal Cortex Activation in Older Adults
September 2, 2026 updated by: Gwangju Health University
Does Park Golf Affect Working Memory?: An fNIRS-Based Randomized Controlled Trial in Community-Dwelling Older Adults
This study investigates whether a park golf program can improve working memory and prefrontal cortex activity in community-dwelling older adults.
A total of 36 older adults (aged 65-85) were randomly assigned to either a park golf group or a health education group.
The park golf group participated in a supervised park golf program (2 sessions per week for 4 weeks, 60 minutes per session), while the health education group attended lectures on healthy aging topics such as nutrition and fall prevention on the same schedule.
Before and after the intervention, participants completed cognitive and physical assessments, including the Korean Montreal Cognitive Assessment (MoCA-K), the Timed Up and Go test, and a spatial working memory task (N-back) performed while brain activity in the prefrontal cortex was measured using functional near-infrared spectroscopy (fNIRS), a non-invasive, radiation-free imaging method.
The findings may help establish evidence for community-based physical activity programs, such as park golf, as a strategy to support cognitive health in older adults.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eun-Sang Lee, PhD
- Phone Number: +82 62-958-7525
- Email: eslee@ghu.ac.kr
Study Locations
-
-
Gwangju
-
Gwangju, Gwangju, South Korea, 61161
- Recruiting
- Gwangju Health University, Buk-gu Campus, Smart Care Village
-
Contact:
- Mincheol Lee
- Phone Number: +82-10-4122-2936
- Email: minchol12@naver.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Community-dwelling older adults aged 65 to 85 years, living independently (excluding those residing in nursing facilities or hospitalized)
- Korean version of the Montreal Cognitive Assessment (MoCA-K) score of 23 or higher (normal cognitive function range)
- Able to walk independently and possess the basic functional capacity required to participate in park golf
- No experience with park golf, or no regular participation in park golf within the past 6 months
- Voluntary written informed consent to participate in the study
Exclusion Criteria:
- History of severe neurological disease (e.g., Parkinson's disease, stroke, dementia) or psychiatric disease (e.g., major depressive disorder, schizophrenia)
- Scalp disease, skull abnormality, or history of craniotomy that could affect fNIRS measurement
- Currently taking medications affecting cognitive function (e.g., anticholinergics, antipsychotics)
- Regular participation in high-intensity exercise programs 3 or more times per week
- Physician-prescribed restriction on physical activity
- Severe visual or auditory impairment that would make assessment difficult, even with correction
- Left-handedness (excluded to control for hemispheric dominance in fNIRS measurement)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Park Golf Group (PGG)
Participants attended supervised park golf sessions twice weekly for 4 weeks (8 sessions total, 60 minutes per session), including warm-up (10 min), park golf skills training and practice (40 min), and cool-down (10 min), held at a community park.
|
A structured, supervised park golf program consisting of 8 sessions over 4 weeks (2 sessions/week, 60 minutes/session).
Each session included a 10-minute warm-up, 40 minutes of park golf technique instruction and practice, and a 10-minute cool-down, conducted at an outdoor community park under the supervision of trained instructors.
|
|
Active Comparator: Health Education Group (HEG)
Participants attended health education lectures on senior health management, nutrition, fall prevention, and chronic disease management, twice weekly for 4 weeks (8 sessions total, 60 minutes per session).
|
A structured health education program consisting of 8 sessions over 4 weeks (2 sessions per week, 60 minutes per session), covering topics such as senior health management, nutrition, fall prevention, and chronic disease management, conducted at a community facility.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Prefrontal Cortex Activation (Beta-value of HbO Concentration)
Time Frame: Change from baseline to 4 weeks (post-intervention)
|
Change in oxygenated hemoglobin (HbO) concentration in the dorsolateral prefrontal cortex (DLPFC), measured as a beta-value derived from general linear model (GLM) analysis during the spatial N-back task, using functional near-infrared spectroscopy (fNIRS).
|
Change from baseline to 4 weeks (post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Working Memory Performance (Spatial N-back Task)
Time Frame: Change from baseline to 4 weeks (post-intervention)
|
Reaction time and accuracy on the 2-back condition of a spatial N-back task, assessing spatial working memory.
Task administered using E-Prime 3.0 software with 1-back and 2-back conditions presented in alternating blocks.
|
Change from baseline to 4 weeks (post-intervention)
|
|
Dynamic Balance (Timed Up and Go Test)
Time Frame: Change from baseline to 4 weeks (post-intervention)
|
Time (in seconds) taken to rise from a chair, walk 3 meters, turn around, and return to sitting, assessing dynamic balance and functional mobility.
|
Change from baseline to 4 weeks (post-intervention)
|
|
Cognitive-Motor Dual-Task Performance (TUG with Naming Animals)
Time Frame: Change from baseline to 4 weeks (post-intervention)
|
Performance on the TUG test while simultaneously naming as many animals as possible, assessing integrated cognitive-motor function.
Measures include dual-task time, dual-task cost, number of animals named, and animals named per 10 seconds.
|
Change from baseline to 4 weeks (post-intervention)
|
|
Global Cognitive Function (Korean Montreal Cognitive Assessment)
Time Frame: Change from baseline to 4 weeks (post-intervention)
|
Overall cognitive function assessed using MoCA-K, covering visuospatial/executive function, naming, attention, language, abstraction, delayed recall, and orientation.
Total score range 0-30.
|
Change from baseline to 4 weeks (post-intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eun-Sang Lee, PhD, Gwangju Health University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 10, 2026
Primary Completion (Estimated)
October 15, 2026
Study Completion (Estimated)
October 15, 2026
Study Registration Dates
First Submitted
September 2, 2026
First Submitted That Met QC Criteria
September 2, 2026
First Posted (Actual)
September 8, 2026
Study Record Updates
Last Update Posted (Actual)
September 8, 2026
Last Update Submitted That Met QC Criteria
September 2, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P01-202607-01-010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data will not be shared beyond this study, in accordance with the informed consent obtained from participants, which specified that collected data would be used solely for this study without secondary use or third-party disclosure.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.